| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |